Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update May 13, 2026
Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor May 13, 2026
Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update May 12, 2026